{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-025568","form_type":"8-K","ticker":"KODK","cik":"0000031235","company_name":"EASTMAN KODAK CO","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.470850+00:00","generated_at":"2026-05-31T11:23:17.547167+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Kodak Q2 revenue falls 9% to $267M; net income drops 26% to $26M","bullets":["Revenue $267M (-9% YoY); GAAP net income $26M (-26%); Operational EBITDA $12M (-45%).","Gross profit percentage improved to 22% from 21%, seventh consecutive quarterly YoY increase.","Cash balance $251M, down $4M from Dec 31, 2023; capex and investments offset by $40M brand licensing proceeds.","Segment: Print revenue $186M (-$29M), Advanced Materials & Chemicals $73M (+$1M), Brand $4M flat.","CEO cites cGMP diagnostic facility on track for 2025; PROSPER ULTRA 520 press commitments from drupa."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-025568","json":"https://secwatch.observer/filing/0001437749-24-025568.json","markdown":"https://secwatch.observer/filing/0001437749-24-025568.md","text":"https://secwatch.observer/filing/0001437749-24-025568.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/31235/000143774924025568/0001437749-24-025568-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/31235/000143774924025568/ekc20240808_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:23:17.547167+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}